IP Library Granted Patent US 10,968,384
Granted Patent B2
US 10,968,384 · App. 15/370,090 · Granted Apr 6, 2021

Well-treatment fluids composition

Inventors: Christopher Raymond Jones (Staffordshire, GB); Stéphanie Edmunds (West Midlands, GB); Jean C. Molina (Midland, TX)
Assignee: SOLVAY USA INC.
C09K8/605C09K8/035C09K8/62C09K2208/26E21B43/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,968,384
App. No.
15/370,090
Granted
Apr 6, 2021
Kind
B2
Abstract

A well treatment fluid composition that includes a tetrakis(hydroxyorgano)phosphonium salt and 1,3-dimethylol-5,5-dimethylhydantoin. Methods for preparing a well treatment fluid composition and treating a subterranean formation are also presented.

Claims (7)

1. A composition consisting of a tetrakis(hydroxyorgano)phosphonium salt, 1,3-dimethylol-5,5-dimethylhydantoin, and optionally one or more members selected from the group consisting of: oxidizing viscosity breakers, quaternary ammonium compounds, and polymers of an unsaturated carboxylic acid or copolymers of an unsaturated carboxylic add with a sulphonic acid, said polymers or copolymers being terminated by a mono- or di-phosphonated unsaturated carboxylic add group or having such monomers incorporated into the polymer backbone, wherein the composition achieves a reduction of bacteria to give a total kill at 5 hour contact time.

2. The composition of claim 1 , wherein the tetrakis(hydroxyorgano)phosphonium salt is selected from the group consisting of tetrakis(hydroxymethyl)phosphonium sulphate, tetrakis(hydroxymethyl)phosphonium chloride, tetrakis(hydroxymethyl)phosphonium phosphate, tetrakis(hydroxymethyl)phosphonium nitrate and tetrakis(hydroxymethyl)phosphonium oxalate.

3. The composition of claim 1 , wherein the composition includes an oxidizing viscosity breaker and the breaker is selected from the group consisting of hydrogen peroxide, sodium persulfate, encapsulated ammonium persulfate, and sodium chlorite.

4. The composition of claim 1 , wherein the mass ratio between the THP salt and 1,3-dimethylol-5,5-dimethylhydantoin is about 1:0.5 to about 1:25.

5. The composition of claim 4 further including at least one oxidizing viscosity breaker.

6. The composition of claim 1 , wherein the composition contains less than 0.2% free formaldehyde after 4 months storage at 50° C.

7. The composition of claim 4 , wherein the composition contains less than 0.2% free formaldehyde after 4 months storage at 50° C.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2023
From: SOLVAY USA INC.
To: ENERGY SOLUTIONS (US) LLC
Reel/Frame 063077/0674 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2017
From: JONES, CHRISTOPHER RAYMOND; EDMUNDS, STÉPHANIE; MOLINA, JEAN C.
To: SOLVAY USA INC.
Reel/Frame 041063/0871 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2016
From: JONES, CHRISTOPHER RAYMOND; EDMUNDS, STÉPHANIE; MOLINA, JEAN C.
To: SOLVAY USA INC.
Reel/Frame 041086/0624 →
Continuity (2)
Provisional Application 62263836 · Dec 7, 2015
Related Publication 20170158949A1 · Jun 8, 2017